EPN 0.00% 2.4¢ epsilon healthcare limited

Medical Cannabis Manufacturing License For Australia’s Medipharm...

  1. 997 Posts.
    lightbulb Created with Sketch. 260
    Medical Cannabis Manufacturing License For Australia’s Medipharm Labs
    27 May 2019

    There’s been a flurry of licences issues by the Office of Drug Control over the past few weeks – well, a flurry compared to activity prior.

    Last week we reported IDT Australia Limited (ASX:IDT) was awarded a medicinal cannabis manufacturing licence, the week prior THC Global was granted a licence to export medical cannabis and earlier in the month, LeafCann Group Pty Ltd said it had secured a medical cannabis manufacturing licence.

    Legislation enabling cultivation of cannabis for medicinal and related research purposes in Australia was passed by Parliament back in February 2016. In Australia, only specific patient groups under medical supervision are able to access medicines and need to jump through a number of hoops to do so. By late February this year, only around 3,100 medicinal cannabis scripts had been approved by the Therapeutic Goods Administration (TGA) – that’s scripts, not patients, and an all-time figure.

    I can smell our manufacturing license, its very very close!!

    GLTAH
    DYOR
 
watchlist Created with Sketch. Add EPN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.